The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 250-256

  Scott, Phillip ^a   Hondowicz, Brian ^a   Eaton, Ashlyn ^a   Scharton Kersten, Tanya ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; LEISHMANIA VACCINE; STIBOGLUCONATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL TRANSFER; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; HEALING; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; INFECTION; LEISHMANIA MAJOR; MOUSE; NATURAL KILLER CELL; NONHUMAN; SKIN LEISHMANIASIS; VACCINE PRODUCTION;

EID: 0030464998     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52674.x     Document Type: Conference Paper

References (18)

1. MOSMANN, T. R. & R. L. COFFMAN. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
2. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
3. SCOTT, P. 1995. T helper cell development and regulation in experimental cutaneous leishmaniasis. Chem. Immunol. 63:
4. SCOTT, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147, 3149-3155.
5. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567-577.
6. SADICK, M. D., F. P. HEINZEL, B. J. HOLADAY, R. T. PU, R. S. DAWKINS & R. M. LOCKSLEY. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171: 115-127.
7. SCOTT, P. & G. TRINCHIERI. 1995. The role of NK cells in host-parasite interactions. Cur. Op. Immunol. In press.
8. AFONSO, L. C. C., T. M. SCHARTON, L. Q. VIERIRA, M. WYSOCKA, G. TRINCHIERI & P. SCOTT. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235-237.
9. HEINZEL, F. P., D. S. SCHOENHAUT, R. M. RERKO, L. E. ROSSER & M. K. GATELY. 1993. Recombinant Interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177: 1505-1509.
10. SYPEK, J. P., C. L. CHUNG, S. E. H. MAYOR, et al. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective Th1 immune response. J. Exp. Med. 177: 1797-1802.
11. + T cells during initiation of infection. J. Exp. Med. 179: 447-456.
12. SCHARTON-KERSTEN, T., L. C. C. AFONSO, M. WYSOCKA, G. TRINCHIERI & P. SCOTT. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154: 5320-5330.
13. HEINZEL, F. P., R. M. RERKO, F. AHMED & E. PEARLMAN. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses. J. Immunol. 155: 730-739.
14. STENGER, S., H. THURING, M. ROLLINGHOFF & C. BOGDAN. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180: 783-793.
15. + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. U.S.A. 90: 10188-10192.
16. NABORS, G. S., L. C. C. AFONSO, J. P. FARRELL & P. SCOTT. 1995. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pentostam. Proc. Natl. Acad. Sci. USA 92: 3142-3146.
17. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179: 589-600.
18. MANETTI, R., P. PARRONCHI, M. G. GIUDIZI, et al. 1993. Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177: 1199-1204.